Clinical Trial Update: FACTS I: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis [Phase 3]

View source ↗

Summary

Phase 3 trial completed evaluating the safety and effectiveness of a new medication for active Ulcerative Colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Not disclosed

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Ulcerative Colitis | Phase 3 | Status: COMPLETED